Related Experiment Videos
Malignant melanoma of the choroid treated with photocoagulation. A 10-year follow-up
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor regression after photocoagulation of malignant melanomas of the choroid: an ultrasonographic study.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·1987
Giant cell astrocytoma of the retina. Clinicopathologic report of a case not associated with Bourneville's disease.
Retina (Philadelphia, Pa.)·1987
Complications of local beta radiation of uveal melanomas.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·1986
[Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
Klinische Monatsblatter fur Augenheilkunde·1984
[Initial results in percutaneous radiotherapy of malignant melanomas of the choroid with the linear accelerator].
Klinische Monatsblatter fur Augenheilkunde·1984
[The Annette von Droste-Hülshoff syndrome].
Klinische Monatsblatter fur Augenheilkunde·1984
Scleral buckling in 2 1/2 to 11-month-old premature infants with retinal detachment associated with acute retrolental fibroplasia.
Modern problems in ophthalmology·1979
[Treatment of complications of venous retinal thromboses with argon laser].
Modern problems in ophthalmology·1979
Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy. A preliminary report.
Modern problems in ophthalmology·1979
Retinal telangiectasias associated with longstanding retinal detachment as a prognostic sign.
Modern problems in ophthalmology·1979
Central serous retinopathy. A generalized disease of the pigment epithelium.
Modern problems in ophthalmology·1979
[Postoperative choroidal detachment and chorioretinal surgery].
Modern problems in ophthalmology·1979
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026